The four-pronged strategy begins with the acquisition of GSK's oncology portfolio ... health division to Lilly for $5.4 billion reflects major changes in the animal health market, sparked by ...

British drugmaker GSK plans to acquire US biotech firm IDRx for $1.15 billion, focusing on innovative tumour treatments. Meanwhile, Moderna cuts sales forecast due to weak vaccine demand, and J&J ...

Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...